Welcome back to Conversations with Orbita! Our host Nate Treloar and our guests Brian McKaig and Aziz Abdullah explore the barriers to medication access and adherence for underserved populations in this episode. These may include patients from rural areas, impoverished urban sectors, low socioeconomic status, the uninsured, from various disadvantaged backgrounds, and more. These social determinants of health produce significant care gaps and exacerbate health inequity.
The COVID-19 pandemic has deepened these disparities as underserved populations are disproportionately impacted by the economic consequences of this pandemic (unemployment, loss of ESI, food instability, etc.).
Hear how pharmaceutical companies can introduce digital tools to engage directly with these underserved populations and provide clinical decision support for healthcare providers. While access isn’t perfect, these digital health solutions offer continuous communication channels for patients and HCPs regarding drug information and support to mitigate some of these barriers to care.